U.S. Markets closed

Johnson & Johnson (JNJ)

New York Stock Exchange Consolidated Issue - New York Stock Exchange Consolidated Issue Delayed Price. Currency in USD
Add to watchlist
134.70+1.25 (+0.94%)
At close: 4:00PM EDT

134.63 -0.07 (-0.05%)
After hours: 6:53PM EDT

People also watch
PGMRKKOPFEXOM
Full screen
Previous Close133.45
Open133.27
Bid134.77 x 100
Ask134.89 x 100
Day's Range132.90 - 134.79
52 Week Range109.32 - 137.08
Volume4,150,182
Avg. Volume5,521,985
Market Cap361.53B
Beta0.64
PE Ratio (TTM)22.64
EPS (TTM)N/A
Earnings DateN/A
Dividend & Yield3.36 (2.52%)
Ex-Dividend Date2017-08-25
1y Target EstN/A
Trade prices are not sourced from all markets
  • Massive California verdict expands J&J's talc battlefield
    Reuters1 hour ago

    Massive California verdict expands J&J's talc battlefield

    A massive California verdict in a lawsuit alleging Johnson & Johnson's (JNJ.N) talc-based products cause cancer has opened a new front in the litigation, upending the company's hopes that the cases were only gaining traction in Missouri, legal experts said. The $417 million award by California jury to a California resident suggested so-called forum-shopping, in which parties seek to file cases in whichever jurisdictions seem most favorable, may not be the main problem facing J&J as it wrestles with some 4,800 outstanding talc lawsuits. J&J, which denies any link between talc and cancer, said in a statement it would appeal Monday's verdict but declined further comment.

  • Associated Press2 hours ago

    AP Top Extended Financial Headlines at 4:46 p.m. EDT

    Iran's new telecommunications minister says Twitter is ready to talk about unblocking access to the microblogging site

  • Fortune6 hours ago

    Does Johnson & Johnson Baby Powder Cause Ovarian Cancer? Here’s What We Know

    A jury just ordered J&J to pay a woman with ovarian cancer $417 million.